Overview

• GPs across the UK have begun prescribing Mounjaro under strict eligibility criteria as part of a phased NHS rollout that started in March
• An estimated 1.5 million Britons are using the GLP-1 injection and are adopting hydration goals of three to four litres per day, high-protein meals and planned healthy snacks to sustain weight loss
• Users report managing common side effects—nausea, gastrointestinal distress and sulphur burps—with low-cost remedies such as peppermint tea and adjusted fluid intake
• The MHRA has launched safety investigations into hundreds of pancreatitis cases and five Mounjaro-linked deaths while issuing new warnings about use in women of childbearing age
• Clinicians caution that Mounjaro reduces appetite signals without eliminating hunger entirely and stress the importance of supervised dosing, nutritional monitoring and regular follow-up